<p>IDEAYA’s drug development programs center around addressing unmet patient needs. Its founder tells Pathfinders in Biopharma why he believes there has never been more opportunity for breakthroughs in the fight against cancer. </p>

IDEAYA’s drug development programs center around addressing unmet patient needs. Its founder tells Pathfinders in Biopharma why he believes there has never been more opportunity for breakthroughs in the fight against cancer.

Biotech with a Mission to Target Unmet Cancer Needs

Perspectives from the cutting edge of biotech and pharma.

The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series.

Lead today. Define tomorrow.

Business

News

Investing

Business News

Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.

Share Biotech with a Mission to Target Unmet Cancer Needs

Sign up to save your podcasts

Biotech with a Mission to Target Unmet Cancer Needs

Biotech with a Mission to Target Unmet Cancer Needs

More shows like Pathfinders in Biopharma

Motley Fool Money

WSJ Your Money Briefing

Exchanges

Odd Lots

WSJ Tech News Briefing

The a16z Show

The Long Run with Luke Timmerman

The Readout Loud

Wall Street Breakfast

Thoughts on the Market

The Journal.

BioCentury This Week

RBC's Markets in Motion

Biotech Hangout

Industries in Motion

Powering Sustainable Ideas

The Markets

Strategic Alternatives

The Top Line

Macro Minutes